Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use FIRAZYR® (icatibant) safely and effectively. See full prescribing information for FIRAZYR. FIRAZYR (icatibant) Injection, for subcutaneous use Initial U.S. Approval: 2011
Medication labelWhy this: Advisory · dailymed-prescription
FIRAZYR® (icatibant) is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.
- generic_name
- icatibant acetate
- product_names
- icatibant acetate
- ndc
- 54092-702, 54092-702-02, 54092-702-03, 54092-702-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en